Skip to Main Content

“Pharma bro” Martin Shkreli was ordered to pay $64.6 million in profits and was banned for life from the pharmaceutical industry for an infamous episode several years ago in which his company purchased an old, lifesaving medicine and then boosted the price by 4,000% overnight.

The decision follows a trial last month in which Shkreli, a former hedge fund manager who quickly became reviled for his smug responses to an outraged public, was accused by a group of federal and state authorities for stifling competition. Also last month, his former company settled the same charges by agreeing to pay $40 million, and his former business partner, Kevin Mulleady, was banned from the industry for seven years.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment